Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy

Recruiting N/A Interventional Study
Geographic Atrophy Secondary to Age-related Macular Degeneration
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
60 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
70 (estimated)
Sponsor
Okuvision GmbH · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Geographic atrophy (GA) is a progressive eye disease that causes the degeneration of the retinal cells, particularly in the macula, leading to vision loss. The goal of this pilot study is to evaluate the safety and the effectiveness of transcorneal electrical stimulation (TES) therapy with the OkuStim 2 System in patients with geographic atrophy (GA). Researchers will compare the effects of two d…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: * Willing and able to understand the study and provide informed consent * 60 years of age or older * Diagnosis of geographic atrophy due to age-related macular degeneration confirmed by imaging * The affected area in the eye must be within a defined size range and clearly visibl…
Contacts

Ruth Schippert, PhD

+49 7121 15935

studies@okuvision.de

CONTACT